Subtopic Deep Dive

Work-Exacerbated Asthma
Research Guide

What is Work-Exacerbated Asthma?

Work-Exacerbated Asthma (WEA) is the worsening of pre-existing asthma symptoms triggered by workplace irritants or exposures, distinct from occupational asthma caused by workplace sensitization.

WEA affects workers with prior asthma through non-sensitizing irritants like dust, fumes, or chemicals. Malo et al. (1993) classify workplace asthma into sensitization-induced occupational asthma and work-exacerbated forms in their foundational text 'Asthma in the Workplace' (396 citations). Distinguishing WEA impacts compensation claims and management strategies.

15
Curated Papers
3
Key Challenges

Why It Matters

WEA complicates clinical management by requiring attribution of symptom worsening to workplace exposures for disability assessments (Malo et al., 1993). Public health interventions target high-risk industries like manufacturing where irritants exacerbate asthma, reducing lost workdays. Kreiss et al. (2002) demonstrate exposure-outcome links in occupational lung disease, informing WEA prevention (481 citations).

Key Research Challenges

Distinguishing WEA from OA

Differentiating work-exacerbated asthma from sensitization-induced occupational asthma relies on history and exposure assessment without specific biomarkers. Malo et al. (1993) outline classification challenges based on temporal patterns and lung function tests. Specific IgE tests confirm OA but not WEA.

Quantifying exposure impact

Attributing asthma exacerbation degree to workplace irritants requires longitudinal spirometry and exposure monitoring. Kreiss et al. (2002) link diacetyl exposure to lung function decline in popcorn workers, highlighting dose-response challenges. Industrial hygiene data often lacks precision for claims.

Management in compensation

Proving workplace causation for WEA in legal claims demands objective metrics amid variable asthma control. European Community Respiratory Health Survey II (2002) tracks incidence factors but notes verification gaps (328 citations). Confounding by personal triggers complicates adjudication.

Essential Papers

1.

Pulmonary fibrosis: pathogenesis, etiology and regulation

Mark S. Wilson, Thomas A. Wynn · 2009 · Mucosal Immunology · 803 citations

2.

Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK

Jonathan Gribbin, Richard Hubbard, Ivan Le Jeune et al. · 2006 · Thorax · 564 citations

The incidence of IPF has more than doubled between 1990 and 2003; this is not due to the ageing of the UK population or an increased ascertainment of milder cases. The incidence of sarcoidosis has ...

3.

Global incidence and prevalence of idiopathic pulmonary fibrosis

Toby M. Maher, Elisabeth Bendstrup, Louis Dron et al. · 2021 · Respiratory Research · 544 citations

4.

Clinical Bronchiolitis Obliterans in Workers at a Microwave-Popcorn Plant

Kathleen Kreiss, Ahmed Gomaa, Greg Kullman et al. · 2002 · New England Journal of Medicine · 481 citations

The excess rates of lung disease and lung-function abnormalities and the relation between exposure and outcomes in this working population indicate that they probably had occupational bronchiolitis...

5.

JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis ― Digest Version ―

Fumio Terasaki, Arata Azuma, Toshihisa Anzai et al. · 2019 · Circulation Journal · 424 citations

6.

Silica, Silicosis, and Autoimmunity

Kenneth Michael Pollard · 2016 · Frontiers in Immunology · 414 citations

Inhalation of dust containing crystalline silica is associated with a number of acute and chronic diseases including systemic autoimmune diseases. Evidence for the link with autoimmune disease come...

7.

Asthma in the Workplace

Jean‐Luc Malo, Moira Chan‐Yeung, David I. Bernstein · 1993 · 396 citations

Introduction Definition and classification of asthma in the workplace I. Leonard Bernstein, David I. Bernstein, Moira Chan-Yeung, Jean-Luc Malo Historical aspects Jack Pepys, I. Leonard Bernstein, ...

Reading Guide

Foundational Papers

Start with Malo et al. (1993) 'Asthma in the Workplace' (396 citations) for WEA classification and history; follow with Kreiss et al. (2002) for irritant exposure cases (481 citations).

Recent Advances

Study European Community Respiratory Health Survey II (2002, 328 citations) for incidence risks and Pollard (2016) on silica-autoimmunity links relevant to exacerbations.

Core Methods

Core techniques: serial spirometry, exposure monitoring, peak flow diaries (Malo et al., 1993); statistical modeling of FEV1 declines (Kreiss et al., 2002).

How PapersFlow Helps You Research Work-Exacerbated Asthma

Discover & Search

Research Agent uses searchPapers with 'Work-Exacerbated Asthma' and filters by citations to find Malo et al. (1993) as the top hit (396 citations), then citationGraph reveals forward citations linking WEA to modern exposure studies. exaSearch queries 'work-exacerbated vs occupational asthma classification' for precise reviews, while findSimilarPapers expands from Kreiss et al. (2002) to irritant-induced cases.

Analyze & Verify

Analysis Agent applies readPaperContent to extract WEA definitions from Malo et al. (1993), then verifyResponse with CoVe cross-checks claims against European Community Respiratory Health Survey II (2002). runPythonAnalysis processes spirometry data from Kreiss et al. (2002) for statistical trends, with GRADE grading assigning high evidence to exposure-response links.

Synthesize & Write

Synthesis Agent detects gaps in WEA biomarkers via contradiction flagging across Malo et al. (1993) and recent surveys, generating exportMermaid diagrams of classification flows. Writing Agent uses latexEditText for manuscript sections, latexSyncCitations to integrate 10+ papers, and latexCompile for camera-ready reviews.

Use Cases

"Analyze lung function decline stats from occupational exposure papers using Python."

Research Agent → searchPapers('workplace irritants lung function') → Analysis Agent → runPythonAnalysis(pandas plot of FEV1 from Kreiss et al. 2002 data) → matplotlib decline trends output.

"Draft LaTeX review distinguishing WEA from occupational asthma."

Synthesis Agent → gap detection on Malo et al. (1993) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile(PDF with WEA flowchart).

"Find GitHub repos analyzing workplace asthma datasets."

Research Agent → searchPapers('work-exacerbated asthma datasets') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → cleaned CSV of exposure models.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers(50+ WEA papers) → citationGraph clustering → GRADE-graded report on triggers. DeepScan applies 7-step analysis with CoVe checkpoints to verify Malo et al. (1993) classifications against surveys. Theorizer generates hypotheses on WEA biomarkers from irritant studies like Kreiss et al. (2002).

Frequently Asked Questions

What defines Work-Exacerbated Asthma?

WEA is pre-existing asthma worsened by workplace irritants without new sensitization, as classified in Malo et al. (1993).

How is WEA diagnosed versus occupational asthma?

Diagnosis uses history, serial peak flows, and exclusion of specific IgE; Malo et al. (1993) detail temporal worsening patterns for WEA.

What are key papers on WEA?

Foundational: Malo et al. (1993, 396 citations) on workplace asthma; Kreiss et al. (2002, 481 citations) on irritant effects.

What open problems exist in WEA research?

Challenges include biomarker absence and exposure quantification for claims; surveys like European Community Respiratory Health Survey II (2002) highlight incidence gaps.

Research Occupational exposure and asthma with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Work-Exacerbated Asthma with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers